A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

about

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

Item

http://www.wikidata.org/entity/Q37322017

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

@en

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.

@nl

type

Item

label

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

@en

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.

@nl

prefLabel

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

@en

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease.

@nl

P1476

A retrospective Aliskiren and Losartan study in non-diabetic chronic kidney disease

@en

P2093

Choong-Meng Chan

http://www.w3.org/2001/XMLSchema#string

Evan Jc Lee

http://www.w3.org/2001/XMLSchema#string

Fook-Chong Stephanie

http://www.w3.org/2001/XMLSchema#string

Grace Sl Lee

http://www.w3.org/2001/XMLSchema#string

Han-Kim Tan

http://www.w3.org/2001/XMLSchema#string

Hui-Lin Choong

http://www.w3.org/2001/XMLSchema#string

Keng-Thye Woo

http://www.w3.org/2001/XMLSchema#string

Kok-Seng Wong

http://www.w3.org/2001/XMLSchema#string

Marjorie Foo

http://www.w3.org/2001/XMLSchema#string

Vathsala Anantharaman

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

Aliskiren vs. angiotensin receptor blockers in hypertension: meta-analysis of randomized controlled trials

The number, quality, and coverage of randomized controlled trials in nephrology.

Rat Ace allele variation determines susceptibility to AngII-induced renal damage

Renal fibrosis: new insights into the pathogenesis and therapeutics.

Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials

Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance.

Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors?

A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension.

Beneficial effects of high-dose losartan in IgA nephritis.

P304

129-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5527/WJN.V2.I4.129

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24255896

http://www.w3.org/2001/XMLSchema#string

P932

3832869

http://www.w3.org/2001/XMLSchema#string